Dose-escalation trial of cladribine using five daily intravenous infusions in patients with advanced hematologic malignancies

Journal of Clinical Oncology

Volumn 14, Issue 1, 1996, Pages 188-195

  Larson, R A ^a   Mick, R ^a   Spielberger, R T ^a   O'Brien, S M ^a   Ratain, M J ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLADRIBINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ARTICLE; BLOOD TOXICITY; BONE MARROW BIOPSY; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE CALCULATION; DOSE RESPONSE; FATIGUE; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOMA; MALE; MYELOID LEUKEMIA; PRIORITY JOURNAL; PROLYMPHOCYTIC LEUKEMIA; RASH; TREATMENT OUTCOME; VERTIGO;

EID: 0030069146     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.1.188     Document Type: Article

References (24)

1. Saven A, Piro LD: 2-Chlorodeoxyadenosine: A newer purine analog active in the treatment of indolent lymphoid malignancies. Ann Intern Med 120:784-791, 1994
2. Piro LD, Carrera CJ, Carson DA, et al: Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine. N Engl J Med 322:1117-1121, 1990
3. Piro LD, Carrera CJ, Beutler E, et al: 2-Chlorodeoxyadenosine: An effective new agent for the treatment of chronic lymphocytic leukemia. Blood 72:1069-1073, 1988
4. Kay AC, Saven A, Carrera CJ, et al: 2-Chlorodeoxyadenosine treatment of low-grade lymphomas. J Clin Oncol 10:371-377, 1992
5. Saven A, Carrera CJ, Carson DA, et al: 2-Chlorodeoxyadenosine: An active agent in the treatment of cutaneous T-cell lymphoma. Blood 80:587-592, 1992
6. Dimopoulos MA, Kantarjian H, Estey E, et al: Treatment of Waldenstrom macroglobulinemia with 2-chlorodeoxyadenosine. Ann Intern Med 118:195-198, 1993
7. Santana VM, Mirro J Jr, Harwood FC, et al: A phase I clinical trial of 2-chlorodeoxyadenosine in pediatric patients with acute leukemia. J Clin Oncol 9:416-422, 1991
8. Santana VM, Mirro J Jr, Kearns C, et al: 2-Chlorodeoxyadenosine produces a high rate of complete hematologic remission in relapsed acute myeloid leukemia. J Clin Oncol 10:364-370, 1992
9. Santana VM, Hurwitz CA, Blakley RL, et al: Complete hematologic remissions induced by 2-chlorodeoxyadenosine in children with newly diagnosed acute myeloid leukemia. Blood 84:1237-1242, 1994
10. Saven A, Kawasaki H, Carrera CJ, et al: 2-Chlorodeoxyadenosine dose escalation in nonhematologic malignancies. J Clin Oncol 11:671-678, 1993
11. Kobayashi K, Vogelzang NJ, O'Brien SM, et al: A phase I study of intermittent infusion cladribine in patients with solid tumors. Cancer 74:168-173, 1994
12. Liliemark J, Juliusson G: On the pharmacokinetics of 2-chloro-2′-deoxyadenosine in humans. Cancer Res 51:5570-5572, 1991
13. Vahdat L, Wong ET, Wile MJ, et al: Therapeutic and neurotoxic effects of 2-chlorodeoxyadenosine in adults with acute myeloid leukemia. Blood 84:3429-3434, 1994
14. Cheson BD, Vena DA, Foss FM, et al: Neurotoxicity of purine analogues: A review. J Clin Oncol 12:2216-2228, 1994
15. Juliusson G, Liliemark J: High complete remission rate from 2-chloro-2′-deoxyadenosine in previously treated patients with B-cell chronic lymphocytic leukemia: Response predicted by rapid decrease of blood lymphocyte count. J Clin Oncol 11:679-689, 1993
16. Cox DR: The Analysis of Binary Data. London, United Kingdom, Methuen, 1970
17. Barton K, Larson RA, O'Brien S, et al: Rapid response of B-cell prolymphocytic leukemia to 2-chlorodeoxyadenosine. J Clin Oncol 10:1821, 1992 (letter)
18. Beutler E, Piro LD, Saven A, et al: 2-Chlorodeoxyadenosine (2-CdA): A potent chemotherapeutic and immunosuppressive nucleoside. Leukemia Lymph 5:1-8, 1991
19. Saven A, Foon KA, Piro LD: 2-Chlorodeoxyadenosine-induced complete remissions in Langerhans-cell histiocytosis. Ann Intern Med 121:430-432, 1994
20. Dimopoulos MA, Kantarjian HM, Estey EH, et al: Chlorodeoxyadenosine in the treatment of multiple myeloma. Blood 79:1626, 1992
21. Robertson LE, Chubb S, Meyn RE, et al: Induction of apoptotic cell death in chronic lymphocytic leukemia by 2-chloro-2′-deoxyadenosine and 9-β-D-arabinosyl-2-fluoroadenine. Blood 81: 143-150, 1993
22. Kearns CM, Blakley RL, Santana VM, et al: Pharmacokinetics of cladribine (2-chlorodeoxyadenosine) in children with acute leukemia. Cancer Res 54:1235-1239, 1994
23. Liliemark J, Juliusson G: Cellular pharmacokinetics of 2-chloro-2′ deoxyadenosine nucleotides: Comparison of intermittent and continuous intravenous infusion and subcutaneous and oral administration in leukemia patients. Clin Cancer Res 1:385-390, 1995
24. Mick R, Larson RA, O'Brien S, et al: Pharmacodynamic evaluation of a phase I trial of cladribine (2CdA) in advanced hematologic malignancies. Proc Am Soc Clin Oncol 36:221, 1995 (abstr)